Controversies in the therapy of low-grade glioma: when and how to treat

References

• World Health Organization Classification of Tumors. Pathology and Genetics: Tumors of the Nervous system. Kleihues P and Cavanee WK (Rds). IARC press, Lyon (2000).
   Google Scholar
• •This publication contains the latest classification of brain tumors and proposes close correlation among pathology, molecular alterations and prognosis of all brain tumor subtypes.
   Google Scholar
• Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology54, 1442–1448 (2000).
   Google Scholar
• Piepmeier J, Christopher S, Spencer D et al Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery38, 872–879 (1996).
   PubMed Web of Science ®Google Scholar
• Pignatti F, Van den Bent M, Curran D et al Prognostic factors for survival in adult patients with cerebral low-grade glioma. Clin. amt. 20,2076-2084 (2002). A retrospective analysis on 610 patients demonstrating that older age, astrocytoma histology, largest tumor diameter with tumor crossing the midline and neurologic deficits before surgery are the most important prognostic factors in patients with low-grade gliomas.
   Google Scholar
• Shaw EG, Scheithauer BW, O'Fallen JR. Supratentorial gliomas: a comparative study by grade and histologic type. Neurooncol 31,273–278 (1997).
   PubMed Web of Science ®Google Scholar
• Brandes AA, Fiorentino MV Pathological and therapeutic aspects of oligodendroglioma. Cancer Treat. Rev 24, 110–111 (1998).
   Web of Science ®Google Scholar
• Barker FG, Chang SM, Huhn SL et al Age and the risk of anaplasia in magnetic resonance non-enhancing supratentorial cerebral tumors. Cancer 80,936–941 (1997).
   PubMed Web of Science ®Google Scholar
• Recht LD, Lew R, Smith TW Suspected low-grade gliomas: is deferring treatment safe? Ann. Neural. 31,431–436 (1992).
   Google Scholar
• Nozaki M, Tada M, Kobayashi H et al. Roles of the functional loss of P53 and other genes in astrocytoma tumorigenesis and progression. Aimooncol. 1,124–137 (1999).
   Google Scholar
• Perry A, Anderl KA, Borell TJ. Detection of P16, RB, CDK4 and P53 gene deletion amplification by fluorescence in situ hybridization (FISH) in 96 gliomas. Am. J. Clin. Farhat. 112,801-809 (1999).
   Google Scholar
• Wang SI, Puc J, LiJ et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57,4183–4186 (1997).
   PubMed Web of Science ®Google Scholar
• Von Deimling, Louis DN, von Ammon K. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas and mixed gliomas. Cancer Res 52, 4277–4279 (1992).
   Google Scholar
• Smith JS, Perry A, Borell TJ et al Alterations of chromosome arms lp and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas. j Clin. Oncol 18,636–645 (2000).
   Google Scholar
• •According to these authors, loss of lp and 19q is prognostic only for pure oligodendroglioma and not for astrocytoma or mixed oligoastrocytoma.
   Google Scholar
• Caimcross JG, Ueki K, Zlatescu MC et al Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. j Natl Cancer Inst. 90, 1473–1479 (1998).
   PubMedGoogle Scholar
• ••This pivotal work demonstrated the relevant prognostic role of lp and 19q deletion in 39 patients with anaplastic oligodendroglioma.
   Google Scholar
• Leighton C, Fisher B, Bauman G et al Supratentorial low-grade gliomas in adults: an analysis of prognostic factors and timing of radiation.j Clin. Oncol 15,1294–1301 (1997).
   PubMed Web of Science ®Google Scholar
• Lote K, Egeland T, Hager B et al Survival, prognostic factors and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. Glitz Chro1.15, 3129–3140 (1997).
   Google Scholar
• Van Veelen MLC, Avezaat Cll, Kros Jm et al Supratentorial low-grade astrocytoma: prognostic factors, dedifferentiation and issue of early versus late surgery. Neurosurg. Psychiatry64, 581–587 (1998).
   PubMed Web of Science ®Google Scholar
• Donahue B, Scott CB, Nelson JS et al Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of radiation therapy oncology group 83–02. Int. J. RadMt. Oncol Biol. Phys. 38,911-914 (1997).
   Google Scholar
• Vecht CJ. Effect of age on treatment decisions in low-grade glioma. j Nemo'.Neurosurg. Psych. 56,1259–1264 (1993).
   PubMed Web of Science ®Google Scholar
• Bauman G, Lote K, Larson D et al Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int. J. Radiat. Oncol Biol. Phys. 45,923–929 (1999).
   PubMed Web of Science ®Google Scholar
• •An extensive database of low-grade glioma patients used to define pretreatment prognostic factors and to identify subgroups with different life expectancy.
   Google Scholar
• Berger MS, Deliganis AV, Dobbins J et al The effect of extent of resection on recurrence in patients with low-grade cerebral hemisphere gliomas. Cancer 74, 1784–1791 (1994).
   PubMed Web of Science ®Google Scholar
• Cairncross JG, Laperriere NJ. Low-grade glioma to treat or not to treat? Arch. Neural. 46, 1238–1242 (1990).
   Google Scholar
• Shaw EG. Low-grade gliomas: to treat or not to treat? A radiation oncologist's viewpoint (editorial). Arch. Neural. 47, 54, (1990)
   Google Scholar
• Wilden JN, Kelly PJ. Computerized stereotactic biopsy for low density CT lesion presenting with epilepsy. J. Neural. Neurosurg. Psychiatry 50, 1302–1305 (1987).
   PubMed Web of Science ®Google Scholar
• Shafqat S, Hedley-White ET, Henson RV. Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neural. 52, 867–869 (1999).
   Google Scholar
• •A statistical demonstration that the rate of anaplastic progression in low-grade astrocytoma is directly correlated with age.
   Google Scholar
• Reijneveld JC, Sitskoom MM, Klein M et al Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology56, 618–623 (2001).
   PubMed Web of Science ®Google Scholar
• •These data suggest that a wait-and-see policy in patients with suspected low-grade glioma has no negative effect on cognitive performance and quality of life.
   Google Scholar
• Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion, location and treatment.j Neurooncol 30, 61–69 (1996).
   PubMed Web of Science ®Google Scholar
• Keles GE, Lamborn KR, Berger MS. Low- grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J. Neurosurg. 95, 735–745 (2001).
   Google Scholar
• Shaw EG, Scheithauer BW, Gilberston DT et al Postoperative radiotherapy of supratentorial low-grade gliomas. int. J. Radiat. Oncol Biol. Phys. 16, 663–668, (1989).
   PubMed Web of Science ®Google Scholar
• Bauman G, Pahapill P, Macdonald D et al Low-grade glioma: a measuring radiographic response to radiotherapy. Can. .1. Neural. Sc]. 26, 18–22 (1999).
   Google Scholar
• Karim ABMF, Afra D, Comu P et al Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European organization for research and treatment of cancer study 22845 with the medical research council study BR04. an interim analysis. Int. J. Radiat. Oncol Biol. Phys. 52, 316–324 ( 2002).
   Google Scholar
• •Early postoperative conventional radiotherapy appears to improve progression free but not overall survival in patients with low-grade glioma.
   Google Scholar
• Brandes A, Pasetto LM, Lumachi F. Endocrine dysfunctions in patients treated for brain tumors. J. Neumoncol 47, 85–92 (2000).
   Google Scholar
• Brandes AA, Rigon A, Monfardini S. Radiotherapy of the brain in the elderly. Contra. Eur. Cancer 36, 447–451 (2000).
   Google Scholar
• Janny P, Cure H, Mohr M et al Low-grade supratentorial astrocytomas: Management and prognostic factors. Cancer 73, 1937–1945 (1994).
   PubMed Web of Science ®Google Scholar
• North CA, North RB, Epstein JA et al Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 66, 6–14 (1990).
   Google Scholar
• Taphoorn MJB, Schiphorst AK, Snock FJ et al Cognitive function and quality of life in patients with low-grade glioma: the impact of radiotherapy. Ann. Neural. 36, 48–54 (1994)
   PubMed Web of Science ®Google Scholar
• Shaw EG, Arusell R, Scheithauer B et al. A prospective randomized trial of low-versus high dose radiation therapy in adults with supratentorial low-grade glioma: initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Co-operative Oncology Group Study. J. Clin. Oncol 20, 2267–2276 (2002).
   PubMed Web of Science ®Google Scholar
• •A demonstration that high-dose radiotherapy achieves higher incidence of radiation necrosis and lower survival rates in low-grade glioma patients.
   Google Scholar
• Karim ABMF, Maat B, Hatlevoll R. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: EORTC study 22844. Int. J. Radiat. Oncol Biol. Phys. 36, 549–556 (1996).
   Google Scholar
• •A relevant randomized study demonstrating that increasing radiotherapy dose to 59.4 Gy does not impact progression-free and overall survival rates compared with 45 Gy, while dimension of the tumor remains strongly prognostic.
   Google Scholar
• Rudoler S, Corn BVV, Werner-Wasik M et al Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era. Am. J. Clin. Oncol 21, 23–27 (1998).
   PubMed Web of Science ®Google Scholar
• Eyre HJ, Crwley JJ, Townsend JJ et al A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. I Neurosurg. 78, 909–914 (1993).
   PubMed Web of Science ®Google Scholar
• •This randomized study demonstrated no statistical difference in median survival between radiotherapy alone and radiotherapy followed by chemotherapy (CCNU). Patient age and performance status were the most relevant prognostic factors for survival.
   Google Scholar
• Mason WP, Krol GS, DeAngelis LM. Low-grade oligodendroglioma responds to chemotherapy. Neural. 46, 203–207 (1996).
   Google Scholar
• Buckner JC, Smith JS, Nelson DF et al Phase II trial of procarbazine, CCNU and vincristine (PCV) as initial therapy in patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy results and associations with chromosome 1 p and 19 q loss. Proc. Am. Soc. Clin. Oncol. 18, 140 (1999) (Abstract).
   Google Scholar
• Thoron L, Colinskas C, Mc Devitt K et al Adjuvant I-PCV chemotherapy for treatment of low-grade oligodendroglioma. Proc. Am. Soc. Clin. OncoL 16, 410 (1997) (Abstract).
   Google Scholar
• Friedman AH, Cokgor I, Edwards S et al Phase II treatment of anaplastic oligodendroglioma and low-grade glioma with temozolomide. Proc. Am. Soc. Clin. Oncol 19, 169 (2000) (Abstract).
   Google Scholar
• Viviers L, Brada M, Hines F et al A Phase II trial of primary chemotherapy with temozolomide in patients with low-grade cerebral gliomas. Proc. Am. Soc. Clin. OncoL 19, 167 (2000) (Abstract).
   Google Scholar
• Brandes AA, Pasetto LM, Vastola F, Monfardini S. Temozolomide in patients with high grade gliomas. Oncology59, 181–186 (2000).
   PubMed Web of Science ®Google Scholar
• Brandes AA, Basso U, Pasetto LM. New strategy developments in brain tumor therapy. Curt: Pharm. Des. 7, 1553–1580 (2001).
   Google Scholar
• Brandes AA, Lacombe D, Vecht C. Future trends in the treatment of brain tumors. Eur. Cancer37, 2297–2301 (2001).
   Google Scholar
• Brandes AA, Basso U, Pasetto LM. Changing boundaries in the treatment of malignant gliomas. Expert Rev Anticancer Ther. 1, 357–370 (2001).
   PubMedGoogle Scholar